Literature DB >> 3060419

Effect of cyclophosphamide on the candidacidal activity of rabbit peritoneal macrophages.

D Kotulová1, M Zalkovicová, J Stefanovic.   

Abstract

Single and repeated intravenous administration of cyclophosphamide significantly decreased the candidacidal activity of rabbit peritoneal macrophages. Using higher doses of the drug, a more pronounced decrease, persisting up to 10 d, was observed. The phagocytic index has not changed significantly 10 d after cyclophosphamide injection as compared with controls. No changes in the phagocytic activity were recorded. The decreased candidacidal activity may be one of the causes of serious microbial infections in cyclophosphamide-treated patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3060419     DOI: 10.1007/bf02925851

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  14 in total

1.  The effect of cyclophosphamide, methotrexate and X-irradiation on the ultrastructure and endocytic capacity of murine peritoneal macrophages.

Authors:  J M Rhodes; A Birch-Andersen; H Ravn
Journal:  Acta Pathol Microbiol Scand A       Date:  1975-09

2.  Age dependent differential effects of cyclophosphamide on natural antibody levels in chickens.

Authors:  A C Ettinger; A A Hirata
Journal:  Dev Comp Immunol       Date:  1982       Impact factor: 3.636

3.  Enhancement of erythrophagocytosis by cyclophosphamide.

Authors:  M Giordano; M A Isturiz
Journal:  Cell Immunol       Date:  1983-10-01       Impact factor: 4.868

4.  Differential effects of cyclophosphamide and cortisone acetate on bronchoalveolar phagocytic cell populations.

Authors:  J E Pennington
Journal:  Am Rev Respir Dis       Date:  1978-08

5.  Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with levamisole or with levamisole plus BCG for malignant lymphoma: a Southwest Oncology Group Study.

Authors:  S E Jones; P N Grozea; T P Miller; E J Van Slyck; S P Balcerzak; J J Costanzi; F S Morrison; H J Eyre; C J Fabian; L Dabich
Journal:  J Clin Oncol       Date:  1985-10       Impact factor: 44.544

6.  Effect of cyclophosphamide on the immune responsiveness of jirds infected with Brugia pahangi.

Authors:  S P Katz; P J Lammie
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

7.  Cyclophosphamide-induced changes in the MRL-lpr/lpr mouse: effects upon cellular composition, immune function, and disease.

Authors:  H R Smith; T M Chused; A D Steinberg
Journal:  Clin Immunol Immunopathol       Date:  1984-01

8.  Reversal of antigen-induced resistance to collagen arthritis by cyclophosphamide.

Authors:  K Arai; N Kaibara; K Takagishi; T Hotokebuchi; C Arita
Journal:  Clin Immunol Immunopathol       Date:  1987-06

9.  Studies of lung infections caused by Pseudomonas aeruginosa in mice treated with cyclophosphamide.

Authors:  P Mayer; H Walzl
Journal:  Infection       Date:  1983 Mar-Apr       Impact factor: 3.553

10.  Compensation of cyclophosphamide immunosuppression by a bacterial immunostimulant (Broncho-Vaxom) in mice.

Authors:  A Bosch; F Lucena; R Parés; J Jofre
Journal:  J Immunopharmacol       Date:  1984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.